A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors
Clinical trial NCT02549937 · COMPLETED
Trial details
- NCT number
- NCT02549937
- Sponsor
- Hutchmed
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2023-04-25
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.